Kristin Bennett, MD
Otolaryngology · Stockton
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
- Since medical school
- 25 years
- Graduated 2001
Offices
3 locations · Sacramento Ear Nose and Throat Surgical and Medical Group Inc · 29 clinicians in this group
Looking this up.
Hospitals listed: St Joseph'S Medical Center of Stockton. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Bennett’s office to ask if they take your plan before you enroll.
California Medical Board record
Licence A94636 · Current
Licensed to practise in California · since 2006 · expires 2028-01-31 · University of Texas Medical School at San Antonio.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- St Joseph'S Medical Center of StocktonStockton, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 67% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.08, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.34, Oct 2024 – Sep 2025
See every measure and the patient survey for St Joseph'S Medical Center of Stockton
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 4 the same, 0 worse of 6 measures. Readmissions: 0 better, 6 the same, 2 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.08 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.34 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.51 (0.54 to 2.47) · 1,424 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.06 (0.78 to 1.33) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.22 (98.08 to 180.36) · 105 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.4 · 127 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.5 · 98 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 13.9 · 257 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 12.2 · 447 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.4 · 405 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9 · 337 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.8 · 3,812 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.29 (0.09 to 0.49) · 6,528 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,304 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (1.49 to 5.48) · 1,467 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.27 (0 to 2.79) · 464 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.22 (0.81 to 3.64) · 1,404 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.16 (1.3 to 13.02) · 455 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.22 (1.5 to 8.93) · 456 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 2.24 (0.78 to 3.71) · 262 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 1.03 (0.53 to 1.53) · 6,521 cases | No different | Jul 2022 – Jun 2024 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.537 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 1.486 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.646 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.7 · 484 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 878 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 22.2 · 265 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 17.1 · 493 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 20.8 · 407 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.3 · 615 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 14.1 · 184 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.4 · 248 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13 (9.6 to 17.6) · 164 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.7 to 1.3) · 290 cases | No different | Jan 2024 – Dec 2024 |
What patients said (541 patients answered, 14% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 68% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 89% |
| Yes, staff "did" give patients information about help after discharge | 89% |
| Doctors "always" explained things so they could understand | 72% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 82% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 41% |
| "YES", patients would definitely recommend the hospital | 67% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 89% |
Original Medicare doctor bills
$172,521
Medicare paid this office $172,521 for 619 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 352 | $58,403 | $97 |
| New patient visit (45+ min) | 156 | $19,000 | $122 |
| Diagnostic exam of voice box using a flexible endoscope | 126 | $18,721 | $103 |
| Short return visit (20+ min) | 161 | $14,548 | $66 |
| Diagnostic exam of nasal passages using an endoscope | 72 | $12,665 | $147 |
See all 14 services
| Return visit (30+ min) | 352 | $58,403 | $97 |
| New patient visit (45+ min) | 156 | $19,000 | $122 |
| Diagnostic exam of voice box using a flexible endoscope | 126 | $18,721 | $103 |
| Short return visit (20+ min) | 161 | $14,548 | $66 |
| Diagnostic exam of nasal passages using an endoscope | 72 | $12,665 | $147 |
| Removal of impacted ear wax | 184 | $9,101 | $33 |
| Comprehensive hearing and speech recognition test | 245 | $7,492 | $27 |
| Critical care, first 30-74 minutes | 18 | $4,429 | $164 |
| New patient visit (30+ min) | 43 | $3,279 | $76 |
| Exam of ear using a microscope | 111 | $3,147 | $23 |
| Test to assess middle ear function | 214 | $3,049 | $13 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 18 | $2,077 | $90 |
| Removal of foreign body in ear canal | 12 | $887 | $68 |
| Test for eardrum and muscle function | 40 | $682 | $16 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Removal or shaving of skin growth | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Removal of impacted ear wax | 188 | 144 | 186 | 246 | 239 | 272 |
| Diagnostic exam of voice box using a flexible endoscope | 172 | 106 | 205 | 153 | 151 | 181 |
| Diagnostic exam of nasal passages using an endoscope | 88 | 31 | 50 | 92 | 75 | 86 |
| Simple control of nose bleed | 19 | – | 20 | 26 | 16 | – |
| Removal of foreign body in ear canal | 13 | – | – | – | 21 | 13 |
| Incision of windpipe for insertion of breathing tube (older than 2 years) | – | 13 | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
619 Original Medicare patients in 2024. Average age 75 · Under 65 9% · 85 and older 17% · Women 58% · Also on Medicaid 20% · Health risk score 1.33. Above the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 75% · Coronary heart disease 30% · Diabetes 27% · Chronic kidney disease 26% · Atrial fibrillation 21% · COPD 20% · Heart failure 18% · Depression 17% · Cancer 14% · Stroke 12% · Dementia 7%.
The office billed $690,200, Medicare allowed $229,740 and paid $172,521; for 2,447 services of 48 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 619 | 2,447 | 75 | 1.33 | $690,200 | $172,521 |
| 2023 | 527 | 2,231 | 75 | 1.35 | $652,906 | $159,317 |
| 2022 | 480 | 2,105 | 75 | 1.34 | $610,968 | $147,919 |
| 2021 | 504 | 2,113 | 74 | 1.36 | $589,442 | $155,661 |
| 2020 | 406 | 1,624 | 73 | 1.41 | $461,988 | $109,320 |
| 2019 | 478 | 2,207 | 73 | 1.45 | $675,306 | $150,944 |
| 2018 | 447 | 2,163 | 74 | 1.46 | $628,020 | $146,591 |
| 2017 | 388 | 1,903 | 74 | 1.51 | $496,442 | $136,165 |
| 2016 | 371 | 1,745 | 73 | 1.48 | $428,007 | $121,975 |
| 2015 | 364 | 1,597 | 73 | 1.38 | $418,014 | $112,459 |
| 2014 | 451 | 1,703 | 73 | 1.34 | $456,337 | $136,787 |
| 2013 | 490 | 1,727 | 72 | 1.38 | $279,255 | $130,214 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Return visit (30+ min) | 252 | $38,965 | $97 |
| Short return visit (20+ min) | 196 | $19,655 | $64 |
| Diagnostic exam of voice box using a flexible endoscope | 115 | $15,601 | $103 |
| New patient visit (45+ min) | 116 | $15,356 | $132 |
| Diagnostic exam of nasal passages using an endoscope | 56 | $11,479 | $153 |
| Removal of impacted ear wax | 161 | $7,944 | $33 |
| Comprehensive hearing and speech recognition test | 203 | $6,758 | $29 |
| New patient visit (30+ min) | 82 | $6,391 | $78 |
| Critical care, first 30-74 minutes | 20 | $6,262 | $169 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $3,240 | $95 |
| Test to assess middle ear function | 164 | $2,524 | $13 |
| Exam of ear using a microscope | 72 | $2,202 | $23 |
| Simple control of nose bleed | 12 | $2,122 | $133 |
| Removal of foreign body in ear canal | 16 | $1,269 | $60 |
| Test for eardrum and muscle function | 45 | $936 | $18 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 21 | $887 | $40 |
2022: 14 services
| Short return visit (20+ min) | 266 | $29,967 | $66 |
| Return visit (30+ min) | 181 | $24,505 | $96 |
| Diagnostic exam of voice box using a flexible endoscope | 101 | $15,887 | $104 |
| Diagnostic exam of nasal passages using an endoscope | 64 | $14,519 | $158 |
| New patient visit (30+ min) | 154 | $12,177 | $79 |
| Removal of impacted ear wax | 161 | $7,974 | $32 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 27 | $6,069 | $83 |
| Comprehensive hearing and speech recognition test | 147 | $4,730 | $29 |
| Simple control of nose bleed | 20 | $2,967 | $114 |
| New patient visit (45+ min) | 24 | $2,698 | $112 |
| Exam of ear using a microscope | 75 | $2,469 | $23 |
| Ct scan of face without contrast | 18 | $2,208 | $110 |
| Test to assess middle ear function | 125 | $1,850 | $13 |
| Test for eardrum and muscle function | 28 | $558 | $18 |
2021: 17 services
| Return visit (30+ min) | 209 | $34,196 | $101 |
| Short return visit (20+ min) | 212 | $24,203 | $72 |
| Diagnostic exam of voice box using a flexible endoscope | 121 | $19,956 | $106 |
| New patient visit (30+ min) | 183 | $15,254 | $83 |
| Diagnostic exam of nasal passages using an endoscope | 34 | $8,438 | $169 |
| Removal of impacted ear wax | 138 | $6,443 | $35 |
| Comprehensive hearing and speech recognition test | 171 | $5,938 | $31 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 30 | $4,993 | $85 |
| New patient visit (45+ min) | 35 | $4,899 | $140 |
| Ct scan of face without contrast | 29 | $3,792 | $118 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,772 | $164 |
| Simple control of nose bleed | 18 | $2,703 | $135 |
| Exam of ear using a microscope | 77 | $2,512 | $25 |
| Test to assess middle ear function | 135 | $2,063 | $14 |
| Diagnostic exam of voice box using a flexible endoscope | 15 | $941 | $55 |
| Short return visit | 16 | $916 | $40 |
| Test for eardrum and muscle function | 40 | $847 | $18 |
2020: 16 services
| Return visit (30+ min) | 195 | $24,974 | $83 |
| New patient visit (30+ min) | 156 | $11,771 | $75 |
| Short return visit (20+ min) | 142 | $11,489 | $56 |
| Diagnostic exam of voice box using a flexible endoscope | 82 | $10,543 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $5,695 | $86 |
| Diagnostic exam of nasal passages using an endoscope | 27 | $4,930 | $159 |
| Removal of impacted ear wax | 112 | $4,510 | $31 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $4,354 | $167 |
| Comprehensive hearing and speech recognition test | 121 | $4,014 | $31 |
| Incision of windpipe for insertion of breathing tube (older than 2 years) | 13 | $3,289 | $253 |
| Ct scan of face without contrast | 17 | $2,167 | $114 |
| Test to assess middle ear function | 108 | $1,531 | $13 |
| Exam of ear using a microscope | 41 | $1,477 | $25 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 31 | $1,213 | $38 |
| Short return visit | 21 | $922 | $34 |
| Test for eardrum and muscle function | 20 | $415 | $19 |
2019: 17 services
| Return visit (30+ min) | 281 | $41,377 | $81 |
| Diagnostic exam of voice box using a flexible endoscope | 121 | $16,112 | $94 |
| Diagnostic exam of nasal passages using an endoscope | 58 | $14,575 | $166 |
| New patient visit (30+ min) | 189 | $13,839 | $73 |
| Short return visit (20+ min) | 142 | $11,576 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 24 | $6,314 | $84 |
| Removal of impacted ear wax | 126 | $6,110 | $33 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 33 | $5,895 | $164 |
| Comprehensive hearing and speech recognition test | 152 | $4,800 | $28 |
| Ct scan of face without contrast | 22 | $2,776 | $111 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 70 | $2,741 | $36 |
| Simple control of nose bleed | 13 | $1,732 | $91 |
| Test to assess middle ear function | 124 | $1,669 | $12 |
| Exam of ear using a microscope | 33 | $1,493 | $24 |
| Removal of foreign body in ear canal | 12 | $852 | $66 |
| Short return visit | 15 | $785 | $37 |
| Test for eardrum and muscle function | 41 | $597 | $14 |
2018: 18 services
| Return visit (30+ min) | 294 | $49,129 | $82 |
| New patient visit (30+ min) | 176 | $13,350 | $76 |
| Diagnostic exam of voice box using a flexible endoscope | 96 | $12,340 | $90 |
| Diagnostic exam of nasal passages using an endoscope | 46 | $12,056 | $175 |
| Comprehensive hearing and speech recognition test | 192 | $7,186 | $30 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 32 | $5,409 | $164 |
| Removal of impacted ear wax | 105 | $4,787 | $34 |
| Incision of windpipe for insertion of breathing tube (older than 2 years) | 13 | $3,609 | $258 |
| Short return visit (20+ min) | 48 | $3,510 | $51 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 24 | $3,164 | $58 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 68 | $2,815 | $40 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 20 | $2,699 | $84 |
| Simple control of nose bleed | 15 | $2,630 | $101 |
| Test to assess middle ear function | 160 | $2,305 | $12 |
| Ct scan of face without contrast | 17 | $2,131 | $112 |
| Exam of ear using a microscope | 21 | $926 | $24 |
| Test for eardrum and muscle function | 51 | $925 | $17 |
| Test for hearing various pitches using earphone and device placed against the bone | 12 | $395 | $33 |
2017: 16 services
| Return visit (30+ min) | 250 | $43,546 | $83 |
| Diagnostic exam of nasal passages using an endoscope | 45 | $15,456 | $174 |
| Diagnostic exam of voice box using a flexible endoscope | 90 | $13,324 | $90 |
| New patient visit (30+ min) | 126 | $9,827 | $78 |
| Short return visit (20+ min) | 104 | $7,778 | $54 |
| Comprehensive hearing and speech recognition test | 148 | $5,149 | $29 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 31 | $5,110 | $160 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 19 | $4,569 | $85 |
| Removal of impacted ear wax | 100 | $4,516 | $33 |
| Simple control of nose bleed | 22 | $2,017 | $67 |
| Ct scan of face without contrast | 15 | $1,767 | $104 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 39 | $1,694 | $41 |
| Test to assess middle ear function | 117 | $1,489 | $11 |
| Exam of the nose and throat using an endoscope | 11 | $1,120 | $93 |
| Exam of ear using a microscope | 25 | $854 | $25 |
| Test for eardrum and muscle function | 40 | $732 | $17 |
2016: 17 services
| Return visit (30+ min) | 229 | $32,490 | $78 |
| Diagnostic exam of voice box using a flexible endoscope | 100 | $13,741 | $90 |
| New patient visit (30+ min) | 128 | $10,262 | $80 |
| Diagnostic exam of nasal passages using an endoscope | 46 | $9,893 | $171 |
| Short return visit (20+ min) | 116 | $8,260 | $54 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 36 | $7,055 | $164 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 29 | $6,909 | $84 |
| Removal of impacted ear wax | 118 | $5,692 | $33 |
| Comprehensive hearing and speech recognition test | 128 | $4,284 | $29 |
| Incision of windpipe for insertion of breathing tube (older than 2 years) | 13 | $4,026 | $310 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 45 | $1,815 | $39 |
| Simple control of nose bleed | 15 | $1,542 | $67 |
| Exam of the nose and throat using an endoscope | 12 | $1,291 | $92 |
| Test to assess middle ear function | 89 | $1,196 | $12 |
| Diagnostic exam of voice box using a flexible endoscope | 11 | $1,019 | $64 |
| Exam of ear using a microscope | 22 | $717 | $24 |
| Test for eardrum and muscle function | 39 | $715 | $17 |
2015: 14 services
| Return visit (30+ min) | 242 | $40,170 | $78 |
| Diagnostic exam of nasal passages using an endoscope | 43 | $13,497 | $173 |
| Diagnostic exam of voice box using a flexible endoscope | 88 | $12,045 | $91 |
| New patient visit (30+ min) | 123 | $9,039 | $73 |
| Removal of impacted ear wax | 113 | $5,691 | $34 |
| Short return visit (20+ min) | 61 | $3,629 | $52 |
| Comprehensive hearing and speech recognition test | 104 | $3,521 | $29 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 16 | $2,612 | $163 |
| Simple control of nose bleed | 12 | $1,708 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 11 | $1,509 | $84 |
| Removal of impacted cerumen (one or both ears) by physician on same date of service as audiologic function testing | 31 | $1,256 | $39 |
| Test to assess middle ear function | 63 | $848 | $12 |
| Exam of ear using a microscope | 19 | $757 | $22 |
| Test for eardrum and muscle function | 36 | $633 | $17 |
2014: 14 services
| Return visit (30+ min) | 262 | $44,663 | $87 |
| Diagnostic exam of voice box using a flexible endoscope | 116 | $18,155 | $94 |
| New patient visit (30+ min) | 190 | $15,894 | $84 |
| Diagnostic exam of nasal passages using an endoscope | 44 | $11,474 | $177 |
| Short return visit (20+ min) | 125 | $9,354 | $59 |
| Removal of impacted ear wax | 156 | $8,150 | $36 |
| Exam of the nose and throat using an endoscope | 16 | $2,527 | $115 |
| Long return visit (40+ min) | 11 | $1,645 | $118 |
| Comprehensive hearing and speech recognition test | 47 | $1,514 | $31 |
| Simple control of nose bleed | 12 | $1,264 | $79 |
| Exam of ear using a microscope | 26 | $1,171 | $25 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 12 | $758 | $32 |
| Test for eardrum and muscle function | 21 | $362 | $17 |
| Test to assess middle ear function | 21 | $264 | $12 |
2013: 13 services
| Short return visit (20+ min) | 350 | $41,355 | $54 |
| New patient visit (45+ min) | 149 | $18,927 | $127 |
| Diagnostic exam of voice box using a flexible endoscope | 109 | $16,624 | $93 |
| Diagnostic exam of nasal passages using an endoscope | 38 | $10,180 | $182 |
| Removal of impacted ear wax | 167 | $8,662 | $37 |
| New patient visit (30+ min) | 61 | $4,056 | $66 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 23 | $2,458 | $107 |
| Simple control of nose bleed | 22 | $2,235 | $75 |
| Return visit (30+ min) | 20 | $2,128 | $79 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 13 | $1,869 | $78 |
| Emergency department visit with moderate level of medical decision making | 15 | $1,447 | $90 |
| Exam of ear using a microscope | 27 | $1,255 | $25 |
| Removal of foreign body in ear canal | 11 | $1,237 | $103 |
Medicaid work
$77,950 in 2024
Medicaid paid $77,950 for 709 billed services this clinician did in 2024, up to 42 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Return visit (30+ min) | 346 | $47,861 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 97 | $19,291 |
| Tympanometry and reflex threshold measurements | 131 | $3,028 |
| Comprehensive audiometry threshold evaluation and speech recognition | 69 | $2,563 |
| Diagnostic flexible fiberoptic laryngoscopy | 16 | $2,211 |
| Short return visit (20+ min) | 25 | $2,084 |
| Removal of impacted ear wax | 13 | $587 |
| Distortion product evoked otoacoustic emissions; limited evaluation (to confirm the presence or absence of hearing disorder, 3-6 frequencies) or transient evoked otoacoustic emissions, with interpretation and report | 12 | $325 |
| 2024 | 709 | 8 | 42 | $77,950 |
| 2023 | 637 | 7 | 36 | $61,906 |
| 2022 | 355 | 4 | 27 | $34,937 |
| 2021 | 624 | 7 | 25 | $52,065 |
| 2020 | 446 | 5 | 33 | $39,939 |
| 2019 | 852 | 6 | 43 | $70,664 |
| 2018 | 1,074 | 6 | 47 | $85,585 |
See the largest Medicaid services in earlier years
2023
| Return visit (30+ min) | 285 | $35,102 |
| Short return visit (20+ min) | 162 | $13,248 |
| OFF/OP CNSLTJ NEW/EST MOD 40 | 27 | $5,336 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 21 | $2,845 |
| Diagnostic flexible fiberoptic laryngoscopy | 15 | $2,087 |
| Comprehensive audiometry threshold evaluation and speech recognition | 54 | $1,796 |
| Tympanometry and reflex threshold measurements | 73 | $1,492 |
2022
| Short return visit (20+ min) | 174 | $13,164 |
| Return visit (30+ min) | 103 | $12,543 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 47 | $6,120 |
| Diagnostic flexible fiberoptic laryngoscopy | 31 | $3,111 |
2021
| Return visit (30+ min) | 222 | $22,996 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 104 | $11,618 |
| Short return visit (20+ min) | 140 | $9,719 |
| Diagnostic flexible fiberoptic laryngoscopy | 41 | $4,081 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 27 | $1,552 |
| Comprehensive audiometry threshold evaluation and speech recognition | 43 | $1,280 |
| Tympanometry and reflex threshold measurements | 47 | $818 |
2020
| Return visit (30+ min) | 219 | $20,466 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 107 | $12,445 |
| Short return visit (20+ min) | 65 | $3,841 |
| Diagnostic flexible fiberoptic laryngoscopy | 28 | $2,667 |
| Tympanometry and reflex threshold measurements | 27 | $519 |
2019
| Return visit (30+ min) | 394 | $34,925 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 231 | $26,562 |
| Diagnostic flexible fiberoptic laryngoscopy | 57 | $4,659 |
| Tympanometry and reflex threshold measurements | 101 | $1,871 |
| Short return visit (20+ min) | 27 | $1,335 |
| Comprehensive audiometry threshold evaluation and speech recognition | 42 | $1,312 |
2018
| Return visit (30+ min) | 455 | $47,391 |
| OFFICE/OP CONSLTJ NEW/EST PT LOW MDM 30 MINUTES | 222 | $25,488 |
| Diagnostic flexible fiberoptic laryngoscopy | 50 | $4,530 |
| Comprehensive audiometry threshold evaluation and speech recognition | 141 | $4,367 |
| Tympanometry and reflex threshold measurements | 191 | $3,506 |
| Distortion product evoked otoacoustic emissions; limited evaluation (to confirm the presence or absence of hearing disorder, 3-6 frequencies) or transient evoked otoacoustic emissions, with interpretation and report | 15 | $304 |
Drugs they prescribed that Part D paid
$14,890
Pharmacies billed $14,890 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
523 generic and fewer than 11 brand-name prescriptions · $14,890 in drug cost · 78 antibiotic prescriptions to 61 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Ofloxacin | 104 | $2,222 | $21 |
| Azelastine | 46 | $1,879 | $41 |
| Fluticasone Propionate | 67 | $1,187 | $18 |
| Ipratropium | 20 | $762 | $38 |
| Omeprazole | 55 | $649 | $12 |
See all 9 drugs
| Ofloxacin | 104 | $2,222 | $21 |
| Azelastine | 46 | $1,879 | $41 |
| Fluticasone Propionate | 67 | $1,187 | $18 |
| Ipratropium | 20 | $762 | $38 |
| Omeprazole | 55 | $649 | $12 |
| Clotrimazole | 13 | $444 | $34 |
| Famotidine | 40 | $418 | $10 |
| Amoxicillin-Clavulanate Potass | 46 | $319 | $7 |
| Montelukast | 41 | $316 | $8 |
Year by year
| 2024 | 530 | 251 | None | None | $14,890 |
| 2023 | 535 | 212 | None | None | $24,803 |
| 2022 | 498 | 205 | None | None | $15,737 |
| 2021 | 436 | 186 | None | None | $11,373 |
| 2020 | 383 | 167 | None | 4% | $11,100 |
| 2019 | 334 | 159 | 4% (13) | 4% | $9,726 |
| 2018 | 330 | 149 | None | None | $10,935 |
| 2017 | 270 | 129 | None | None | $8,210 |
| 2016 | 268 | 115 | None | None | $5,529 |
| 2015 | 373 | 144 | 4% (13) | 3% | $11,532 |
| 2014 | 458 | 178 | 5% (23) | 4% | $10,680 |
| 2013 | 476 | 193 | 4% (20) | 8% | $14,238 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 10 drugs
| Ofloxacin | 75 | $3,292 | $44 |
| Omeprazole | 64 | $1,278 | $20 |
| Azelastine | 34 | $1,257 | $37 |
| Fluticasone Propionate | 81 | $1,222 | $15 |
| Ipratropium | 25 | $1,094 | $44 |
| Amoxicillin-Clavulanate Potass | 53 | $699 | $13 |
| Clotrimazole | 15 | $650 | $43 |
| Famotidine | 52 | $455 | $9 |
| Montelukast | 31 | $271 | $9 |
| Sulfamethoxazole-Trimethoprim | 20 | $127 | $6 |
2022: 12 drugs
| Ofloxacin | 84 | $7,551 | $90 |
| Azelastine | 40 | $1,503 | $38 |
| Amoxicillin-Clavulanate Potass | 49 | $871 | $18 |
| Fluticasone Propionate | 68 | $715 | $11 |
| Clotrimazole | 15 | $544 | $36 |
| Omeprazole | 72 | $491 | $7 |
| Ipratropium | 11 | $439 | $40 |
| Famotidine | 31 | $257 | $8 |
| Prednisone | 13 | $230 | $18 |
| Triamterene-Hydrochlorothiazid | 12 | $188 | $16 |
| Montelukast | 12 | $150 | $13 |
| Sulfamethoxazole-Trimethoprim | 13 | $75 | $6 |
2021: 10 drugs
| Ofloxacin | 76 | $4,110 | $54 |
| Azelastine | 19 | $715 | $38 |
| Ipratropium | 13 | $649 | $50 |
| Fluticasone Propionate | 42 | $572 | $14 |
| Omeprazole | 94 | $533 | $6 |
| Amoxicillin-Clavulanate Potass | 31 | $505 | $16 |
| Triamterene-Hydrochlorothiazid | 11 | $245 | $22 |
| Famotidine | 19 | $140 | $7 |
| Montelukast | 16 | $128 | $8 |
| Prednisone | 15 | $126 | $8 |
2020: 10 drugs
| Ciprodex | 13 | $3,293 | $253 |
| Ofloxacin | 65 | $3,177 | $49 |
| Amoxicillin-Clavulanate Potass | 36 | $638 | $18 |
| Fluticasone Propionate | 39 | $615 | $16 |
| Omeprazole | 74 | $588 | $8 |
| Ipratropium | 12 | $447 | $37 |
| Triamterene-Hydrochlorothiazid | 21 | $360 | $17 |
| Cephalexin | 12 | $133 | $11 |
| Montelukast | 14 | $94 | $7 |
| Sulfamethoxazole-Trimethoprim | 12 | $43 | $4 |
2019: 7 drugs
| Ofloxacin | 51 | $2,949 | $58 |
| Ciprodex | 12 | $2,895 | $241 |
| Amoxicillin-Clavulanate Potass | 38 | $742 | $20 |
| Omeprazole | 67 | $608 | $9 |
| Fluticasone Propionate | 35 | $324 | $9 |
| Nystatin | 11 | $197 | $18 |
| Cephalexin | 12 | $102 | $9 |
2018: 8 drugs
| Ofloxacin | 53 | $5,939 | $112 |
| Fluticasone Propionate | 48 | $631 | $13 |
| Amoxicillin-Clavulanate Potass | 33 | $486 | $15 |
| Omeprazole | 61 | $446 | $7 |
| Ipratropium | 12 | $267 | $22 |
| Montelukast | 11 | $158 | $14 |
| Prednisone | 11 | $141 | $13 |
| Cephalexin | 11 | $120 | $11 |
2017: 5 drugs
| Ofloxacin | 33 | $3,392 | $103 |
| Fluticasone Propionate | 37 | $409 | $11 |
| Amoxicillin-Clavulanate Potass | 21 | $329 | $16 |
| Omeprazole | 60 | $313 | $5 |
| Nystatin | 13 | $200 | $15 |
2016: 5 drugs
| Ofloxacin | 38 | $1,637 | $43 |
| Fluticasone Propionate | 59 | $646 | $11 |
| Amoxicillin-Clavulanate Potass | 27 | $577 | $21 |
| Omeprazole | 53 | $314 | $6 |
| Montelukast | 18 | $149 | $8 |
2015: 8 drugs
| Ofloxacin | 53 | $2,728 | $51 |
| Triamcinolone Acetonide | 27 | $2,140 | $79 |
| Fluticasone Propionate | 67 | $732 | $11 |
| Azelastine | 11 | $461 | $42 |
| Omeprazole | 69 | $444 | $6 |
| Clotrimazole | 17 | $431 | $25 |
| Amoxicillin-Clavulanate Potass | 26 | $389 | $15 |
| Montelukast | 13 | $119 | $9 |
2014: 9 drugs
| Fluticasone Propionate | 114 | $2,333 | $20 |
| Ofloxacin | 66 | $1,600 | $24 |
| Triamcinolone Acetonide | 19 | $1,529 | $80 |
| Omeprazole | 87 | $937 | $11 |
| Amox Tr-Potassium Clavulanate | 21 | $383 | $18 |
| Montelukast | 13 | $308 | $24 |
| Clotrimazole | 11 | $161 | $15 |
| Hydrocodone-Acetaminophen | 16 | $158 | $10 |
| Ciprofloxacin | 15 | $108 | $7 |
2013: 9 drugs
| Fluticasone Propionate | 173 | $4,133 | $24 |
| Nasonex | 21 | $2,978 | $142 |
| Ofloxacin | 36 | $892 | $25 |
| Omeprazole | 67 | $792 | $12 |
| Amox Tr-Potassium Clavulanate | 18 | $676 | $38 |
| Montelukast | 14 | $378 | $27 |
| Cephalexin | 13 | $138 | $11 |
| Triamterene-Hctz | 13 | $122 | $9 |
| Hydrocodone-Acetaminophen | 12 | $122 | $10 |
Money from drug and device companies
$199 in 2025
| 2025 | 4 | 9 | None | $199 |
| 2024 | 7 | 41 | None | $495 |
| 2023 | 6 | 10 | None | $199 |
| 2022 | 9 | 16 | None | $303 |
| 2021 | 7 | 12 | None | $232 |
| 2020 | 4 | 8 | None | $270 |
| 2019 | 4 | 8 | None | $257 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Nucala | $91 | 5 payments
|
| Medtronic | Stealth Autoguide System | $75 | 2 payments
|
| Genzyme | Dupixent | $18 | 1 payment
|
| Inspire Medical Systems | Inspire | $14 | 1 payment
|
See all 9 published payments
| GlaxoSmithKline | Meals · 2025-11-25 | Nucala | $17 |
| Medtronic | Meals · 2025-07-21 | Stealth Autoguide System | $44 |
| GlaxoSmithKline | Meals · 2025-07-15 | Nucala | $17 |
| GlaxoSmithKline | Meals · 2025-05-27 | Nucala | $15 |
| Genzyme | Meals · 2025-05-19 | Dupixent | $18 |
| GlaxoSmithKline | Meals · 2025-04-17 | Nucala | $19 |
| GlaxoSmithKline | Meals · 2025-02-25 | Nucala | $22 |
| Inspire Medical Systems | Meals · 2025-02-14 | Inspire | $14 |
| Medtronic | Meals · 2025-01-07 | Stealth Autoguide System | $31 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $495
| GlaxoSmithKline | Nucala | $145 | 27 payments
|
| Inspire Medical Systems | Inspire | $80 | 3 payments
|
| Genzyme | Dupixent | $74 | 3 payments
|
| Optinose US | Xhance | $71 | 4 payments
|
| Regeneron Healthcare Solutions | Dupixent | $64 | 2 payments
|
| Smith+Nephew | Tula | $39 | 1 payment
|
| Ethicon US | Stratafix | $24 | 1 payment
|
2023: $199
| Genzyme | Dupixent | $56 | 3 payments
|
| Regeneron Healthcare Solutions | Dupixent | $36 | 1 payment
|
| GlaxoSmithKline | Nucala | $34 | 2 payments
|
| Tactile Systems Technology | Flexitouch Plus | $32 | 2 payments
|
| Novartis Pharmaceuticals | Xolair | $23 | 1 payment
|
| Inspire Medical Systems | Inspire | $18 | 1 payment
|
2022: $303
| GlaxoSmithKline | Nucala | $82 | 6 payments
|
| OptiNose US | Xhance | $44 | 2 payments
|
| Acclarent | Acclarent Aera | $32 | 1 payment
|
| Stryker | Xpress Ent Dilation System | $31 | 1 payment
|
| Regeneron Healthcare Solutions | Dupixent | $27 | 1 payment
|
| Medtronic | Ligasure | $26 | 2 payments
|
| Aerin Medical | None | $23 | 1 payment
|
| ALK-Abello | Otiprio | $19 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $19 | 1 payment
|
2021: $232
| Regeneron Healthcare Solutions | Dupixent | $61 | 3 payments
|
| Smith+Nephew | Halo | $48 | 2 payments
|
| GlaxoSmithKline | Nucala | $45 | 3 payments
|
| Genzyme | Dupixent | $25 | 1 payment
|
| Intersect ENT | Sinuva | $21 | 1 payment
|
| Novartis Pharmaceuticals | Xolair | $19 | 1 payment
|
| Forte Bio-Pharma | Prolate | $12 | 1 payment
|
2020: $270
| Acclarent | Acclarent Navwire Sinus Navigation Guidewire | $127 | 2 payments
|
| OptiNose US | Xhance | $64 | 3 payments
|
| Smith+Nephew | Stravix | $62 | 2 payments
|
| Stryker | Entellus - Xpress Ent Dilation System | $16 | 1 payment
|
2019: $257
| Smith+Nephew | Grafix Pl Prime | $113 | 3 payments
|
| Aerin Medical | Vivaer Rf Stylus | $78 | 2 payments
|
| OptiNose US | Xhance | $45 | 2 payments
|
| Intersect ENT | Sinuva | $21 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 68.0 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1922047299
- Licence
- CA A94636California A94636: Current · expires 2028-01-31
- Video visits
- Lists video visits
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Otolaryngology (207Y00000X)
- Mailing address
- 1111 Exposition Blvd, Bldg 700, Sacramento, CA, 95815
- NPI first listed
- 2006-06-05
- NPI last updated
- 2020-05-07
- NPI record certified
- 2020-05-07
This is when the NPI record was last certified, not a medical board exam.